Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michèle Algarte Genin"'
Autor:
Olivier Lambotte, Pierre Delobel, Jean-Philippe Spano, Kevin Bihan, Dominique Costagliola, Christine Katlama, Anne-Geneviève Marcelin, Laurent Greillier, Baptiste Abbar, Armelle Lavole, Séverine Gibowski, Cathia Soulié, Lambert Assoumou, Raghiatou Baldé, Thierry Allegre, Alain Makinson, Olivia Zaegel-Faucher, Marianne Veyri, Mathilde Bertheau, Michèle Algarte Genin, Marine Baron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 8 (2024)
Background Immune checkpoint inhibitors (ICIs) have been a major advance in cancer management. However, we still lack prospective real-world data regarding their usage in people with HIV infection (PWH).Methods The ANRS CO24 OncoVIHAC study (NCT03354
Externí odkaz:
https://doaj.org/article/69894f86f8e24e439ccac9ecea674593
Autor:
Guillaume Martin-Blondel, François-Xavier Lescure, Lambert Assoumou, Charlotte Charpentier, Jean-Marc Chapplain, Thomas Perpoint, Gaspard Grouteau, Hugues Cordel, Gilles Pialoux, Jérome Pacanowski, Michael Thy, Adeline Bauvois, Didier Laureillard, Fadia Hamrouni, Michèle Algarte-Genin, Julien Poissy, Diane Descamps, Dominique Costagliola, for the CoCliCo Study Group
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. Methods We conducted an exposed/unexposed cohort study with retrospective data collection, comparing
Externí odkaz:
https://doaj.org/article/38dbe33e16244ff9b51148a29dbca9f1
Autor:
Jean-Michel Molina, Jade Ghosn, Lambert Assoumou, Constance Delaugerre, Michèle Algarte-Genin, Gilles Pialoux, Christine Katlama, Laurence Slama, Geoffroy Liegeon, Lydie Beniguel, Michel Ohayon, Hanane Mouhim, Lauriane Goldwirt, Bruno Spire, Bénédicte Loze, Laure Surgers, Juliette Pavie, Jérémy Lourenco, Mohamed Ben-Mechlia, Soizic Le Mestre, Daniela Rojas-Castro, Dominique Costagliola
Publikováno v:
The Lancet HIV
The Lancet HIV, 2022, 9 (8), pp.e554-e562. ⟨10.1016/S2352-3018(22)00133-3⟩
The Lancet HIV, 2022, 9 (8), pp.e554-e562. ⟨10.1016/S2352-3018(22)00133-3⟩
International audience; BackgroundThere are few data available regarding the use of on-demand pre-exposure prophylaxis (PrEP) for HIV prevention. We aimed to assess PrEP effectiveness, adherence, and safety in adults using daily or on-demand PrEP.Met
Autor:
Guillaume, Martin-Blondel, François-Xavier, Lescure, Lambert, Assoumou, Charlotte, Charpentier, Jean-Marc, Chapplain, Thomas, Perpoint, Gaspard, Grouteau, Hugues, Cordel, Gilles, Pialoux, Jérome, Pacanowski, Michael, Thy, Adeline, Bauvois, Didier, Laureillard, Fadia, Hamrouni, Michèle, Algarte-Genin, Julien, Poissy, Diane, Descamps, Dominique, Costagliola, Olivier, Grossi
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, 2022, 22, pp.540. ⟨10.1186/s12879-022-07508-x⟩
BMC Infectious Diseases, 2022, 22, pp.540. ⟨10.1186/s12879-022-07508-x⟩
Background The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. Methods We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients